Clover Health Investments, Corp.
CLOV
$2.49
$0.041.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.98% | 2.83% | |||
| Total Other Revenue | 124.81% | 43.67% | |||
| Total Revenue | 3.98% | 3.31% | |||
| Cost of Revenue | 12.03% | 6.95% | |||
| Gross Profit | -26.55% | -8.50% | |||
| SG&A Expenses | -11.52% | 0.09% | |||
| Depreciation & Amortization | 3.05% | -15.45% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.73% | 5.30% | |||
| Operating Income | -130.86% | -728.81% | |||
| Income Before Tax | -130.45% | -730.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -130.45% | -730.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -130.45% | -730.30% | |||
| EBIT | -130.86% | -728.81% | |||
| EBITDA | -135.82% | -1,158.04% | |||
| EPS Basic | -128.37% | -700.00% | |||
| Normalized Basic EPS | -128.46% | -712.50% | |||
| EPS Diluted | -128.37% | -700.00% | |||
| Normalized Diluted EPS | -128.46% | -712.50% | |||
| Average Basic Shares Outstanding | 0.73% | 2.41% | |||
| Average Diluted Shares Outstanding | 0.73% | 2.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||